These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12490078)

  • 21. Changes in plasma low-density lipoprotein (LDL)- and high-density lipoprotein cholesterol in hypo- and hyperthyroid patients are related to changes in free thyroxine, not to polymorphisms in LDL receptor or cholesterol ester transfer protein genes.
    Diekman MJ; Anghelescu N; Endert E; Bakker O; Wiersinga WM
    J Clin Endocrinol Metab; 2000 May; 85(5):1857-62. PubMed ID: 10843165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation response and effectiveness of thyroid hormone replacement treatment on lipid profile and function in elderly patients with subclinical hypothyroidism.
    Arinzon Z; Zuta A; Peisakh A; Feldman J; Berner Y
    Arch Gerontol Geriatr; 2007; 44(1):13-9. PubMed ID: 16621071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Even mildly elevated TSH is associated with an atherogenic lipid profile in postmenopausal women with subclinical hypothyroidism.
    Geng H; Zhang X; Wang C; Zhao M; Yu C; Zhang B; Wang Y; Ban B; Zhao J
    Endocr Res; 2015; 40(1):1-7. PubMed ID: 24679183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of L-thyroxine replacement on apolipoprotein B-48 in overt and subclinical hypothyroid patients.
    Ito M; Kitanaka A; Arishima T; Kudo T; Nishihara E; Kubota S; Amino N; Hiraiwa T; Hanafusa T; Miyauchi A
    Endocr J; 2013; 60(1):65-71. PubMed ID: 22986485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature.
    Danese MD; Ladenson PW; Meinert CL; Powe NR
    J Clin Endocrinol Metab; 2000 Sep; 85(9):2993-3001. PubMed ID: 10999775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thyroid function and cholesterol level: paradoxical findings in large groups of population with high cholesterol food intake.
    Langer P; Kocan A; Tajtakova M; Petrik J; Koska J; Hucková M; Hanzen E; Ksinantova L; Radikova Z; Imrich R; Trnovec T; Blazicek P; Sebokova E; Klimes I
    Endocr Regul; 2003 Sep; 37(3):175-80. PubMed ID: 14986723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subclinical hypothyroidism and the risk of hypercholesterolemia.
    Hueston WJ; Pearson WS
    Ann Fam Med; 2004; 2(4):351-5. PubMed ID: 15335135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A study on serum homocysteine and oxidized LDL as markers of cardiovascular risk in patients with overt hypothyroidism.
    Kumar Singh N; Suri A; Kumari M; Kaushik P
    Horm Mol Biol Clin Investig; 2022 Sep; 43(3):329-335. PubMed ID: 35179003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subclinical hypothyroidism and its association with cardiovascular risk factors.
    Sharma R; Sharma TK; Kaushik GG; Sharma S; Vardey SK; Sinha M
    Clin Lab; 2011; 57(9-10):719-24. PubMed ID: 22029187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of procollagen III peptide as a marker of tissue hyperthyroidism in long-term treated women with TSH suppressive doses of thyroxine.
    Zulewski H; Siggelkow H; Walden C; Becker W; Hüfner M
    Exp Clin Endocrinol Diabetes; 1999; 107(3):190-4. PubMed ID: 10376444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipid profiles in the untreated patients with Hashimoto thyroiditis and the effects of thyroxine treatment on subclinical hypothyroidism with Hashimoto thyroiditis.
    Tagami T; Tamanaha T; Shimazu S; Honda K; Nanba K; Nomura H; Yoriko SU; Usui T; Shimatsu A; Naruse M
    Endocr J; 2010; 57(3):253-8. PubMed ID: 20032565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of L-thyroxine therapy on lipoprotein fractions in overt and subclinical hypothyroidism, with special reference to lipoprotein(a).
    Arem R; Escalante DA; Arem N; Morrisett JD; Patsch W
    Metabolism; 1995 Dec; 44(12):1559-63. PubMed ID: 8786724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for cardiovascular disease in women with subclinical hypothyroidism.
    Luboshitzky R; Aviv A; Herer P; Lavie L
    Thyroid; 2002 May; 12(5):421-5. PubMed ID: 12097204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum lipids, tHcy, hs-CRP, MDA and PON-1 levels in SCH and overt hypothyroidism: effect of treatment.
    Singh S; Dey Sarkar P
    Acta Biomed; 2014 Aug; 85(2):127-34. PubMed ID: 25245648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of L-thyroxine replacement therapy on ischemia-modified albümin and malondialdehyde levels in patients with overt and subclinical hypothyroidism.
    Erem C; Suleyman AK; Civan N; Mentese A; Nuhoglu İ; Uzun A; Coskun H; Deger O
    Endocr Res; 2016 Nov; 41(4):350-360. PubMed ID: 27111422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of L-thyroxine replacement therapy on carotid intima-media thickness in patients with primary hypothyroidism.
    Cakal E; Turgut AT; Demirbas B; Ozkaya M; Cakal B; Serter R; Aral Y
    Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):294-300. PubMed ID: 19085705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of thyroid substitution on hypercholesterolaemia in patients with subclinical hypothyroidism: a reanalysis of intervention studies.
    Tanis BC; Westendorp GJ; Smelt HM
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):643-9. PubMed ID: 8759176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular and atherogenic aspects of subclinical hypothyroidism.
    Kahaly GJ
    Thyroid; 2000 Aug; 10(8):665-79. PubMed ID: 11014311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of overt and subclinical hypothyroidism. Factors influencing L-thyroxine dosage.
    Rezzónico JN; Pusiol E; Saravi FD; Rezzónico M; Bossa N
    Medicina (B Aires); 1999; 59(6):698-704. PubMed ID: 10752211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Changes in plasma concentrations of osteoprotegerin before and after levothyroxine replacement therapy in hypothyroid patients].
    Xiang GD; Sun HL; Zhao LS; Hou J; Yue L
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(30):2121-5. PubMed ID: 17988532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.